<DOC>
	<DOC>NCT00695604</DOC>
	<brief_summary>The purpose of this study is to to compare the effects of high-dose ICS vs. placebo in adults with chronic stable asthma.</brief_summary>
	<brief_title>Repeated High-dose Inhaled Corticosteroids for Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion criteria: Physician diagnosis of asthma. Age ≥18 years and ≤50 years Evidence of airflow obstruction as measured by spirometry and flowvolume loop per American Thoracic Society guidelines. Treatment for asthma with: daily inhaled corticosteroids and longacting beta2agonists, AND asneeded use of a shortacting beta2agonist Exclusion criteria: History of &gt;10 packyear tobacco use Other pulmonary or cardiac diagnosis that is actively being treated History of adverse events or allergy to fluticasone Systemic corticosteroid therapy within 7 days of study visit Inability to obtain written informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Acute asthma</keyword>
	<keyword>fluticasone</keyword>
	<keyword>inhaled corticosteroids</keyword>
</DOC>